You are here

  • Home
  • Archive
  • Volume 82, Issue 8
  • Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’

Citation Tools

Article menu
Download PDFPDF
Correspondence
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Winkler MS, Korsten P, Binder C, et al
Correspondence on ‘Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case–control study’
Annals of the Rheumatic Diseases 2023;82:e182.